Bioventus has acquired Bioness, Inc., a global leader in neuromodulation and rehabilitation medical devices through its innovative peripheral nerve stimulation (“PNS”) therapy and premium rehabilitation solutions, for $45 million in up-front consideration, with up to $65 million of contingent consideration related to the achievement of certain key milestones. Click here to read the press release. We also have a Q&A about the acquisition.
